Investigation of the Effects of Visual-Motor Based Training on Upper Extremity Functions in Individuals With Stroke

Not Applicable

Not yet recruiting

• Conditions: Stroke

• Registration Number: NCT07055945
• Lead Sponsor: Baskent University

Brief Summary

The purpose of this study is to investigate the effects of visual-motor based training and physiotherapy program on upper extremity functions in individuals with stroke and to compare with physiotherapy program.

Detailed Description

Stroke is a clinical syndrome characterized by the sudden onset of signs and symptoms due to a localized loss of cerebral function, in the absence of any apparent cause other than a vascular origin.More than 50% of patients experience various impairments and dependence on others following a stroke. One of the primary reasons for this condition is problems affecting the upper extremity.

The Light Trainer system allows for the repetitive and non-repetitive practice of an activity. It enables goal-oriented, active participation, providing an enjoyable experience that engages the whole body. The difficulty level can be adjusted and is tailored to the individual's response ability. With these features, it supports motor learning. Given these characteristics, the Light Trainer system is considered suitable for use in patients with sensory-motor-cognitive disorders, such as those with stroke, multiple sclerosis, and Parkinson's disease. A literature review reveals that task-oriented exercises and virtual reality are commonly used for visual-motor training; however, no studies have been found involving this new system

The first aim of this study is to investigate the effects of visual-motor based training and physiotherapy program on upper extremity functions in individuals with stroke and to compare with physiotherapy program.

The second aim of this study is to investigate the effects of visual-motor based training and physiotherapy program on cognitive functions and trunk in individuals with stroke and to compare with physiotherapy program.

Study Timeline

• Study First Submitted: 2025-05-07
• Status Verified: 2025-07
• Study First Submitted QC: 2025-07-04
• Last Update Submitted: 2025-07-04
• Study First Posted: 2025-07-09
• Last Update Posted: 2025-07-09
• Study Start: 2025-08-15
• Primary Completion: 2025-12-15
• Study Completion: 2025-12-30

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 38

Inclusion Criteria

Not provided

Exclusion Criteria

• Presence of hemispatial neglect syndrome
• Ataxia due to posterior circulatory ischemia
• Bilateral involvement (bilateral hemiparesis)
• Botulinum toxin injection in the last three months
• Physiotherapy treatment within the last 6 months
• Orthopedic problems such as shoulder subluxation, shoulder pain, or contractures in the hand or wrist
• Previous upper extremity or thoracic surgery
• Vision problems related to stroke (hemianopsia)
• Color blindness

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Modified Ashworth Scale	eight weeks	Modified Ashworth Scale (MAS) will be used to evaluate the muscle tone of the \*\*shoulder, elbow, wrist, and finger flexors\*\* in post-stroke patients. This scale will be applied both as part of the \*\*initial assessment\*\* for determining eligibility and to evaluate the \*\*effectiveness of the intervention\*\* by comparing pre- and post-treatment scores. MAS grades muscle tone on a 6-point ordinal scale.Each measurement will be performed twice. Data will be entered into the statistical database both as ordinal values (0 to 4) and using a coding system for further analysis. Patients will be evaluated pre- and post-treatment using the MAS.
Fugl-Meyer Upper Extremity Assessment	eight weeks	The Fugl-Meyer Motor Assessment Scale is a performance-based motor impairment scale developed to evaluate recovery in individuals with stroke. This scale includes subtests that assess upper and lower extremity functions, balance, sensation, and posture. In our study, the upper extremity gross and fine motor functions of patients will be assessed using the Fugl-Meyer Upper Extremity (FM-UE) Assessment Scale. The maximum score that can be obtained in the assessment is 66, with higher scores indicating better motor function. Patients will be evaluated pre- and post-treatment using the Fugl-Meyer Assessment Scale.
Wolf Motor Function Test	eight weeks	The Wolf Motor Function Test (WMFT) is a test developed to evaluate motor skills in patients with moderate to severe upper extremity motor deficits The original version was developed by Wolf and colleagues. In our study, the modified version developed by Morris and colleagues will be used.Data will be collected for 15 activities in two areas: "functional ability" and "performance time". The duration of the test is 30-45 minutes.Each activity will be rated by the physiotherapist using a scale of 0 to 5 based on the functional ability section, where:0 = "The affected hand is not used at all during the activity",5 = "Normal movement".The average score for functional ability will be calculated, and based on this, the patient will receive a score between 0 and 5, with higher scores indicating good functional ability.The performance time will be recorded in seconds.The maximum time given to complete an activity is 120seconds.Patients will be evaluated pre- and post-treatment using the WMFT
Purdue Pegboard Test	eight weeks	The Purdue Pegboard Test(PPT) is used to assess the motor skills and coordination of the upper extremity. The test consists of a board with two parallel rows of 25 holes, along with pegs, rings, and small pins.In our study, upper extremity motor skills and coordination will be evaluated using the PPT. Scoring: Each pin inserted with the right or left hand earns 1 point, each pair of pins inserted with both hands earns 1 point, and each completed combination (pin, washer, and nut) is worth 4 points. Patients will be evaluated pre- and post-treatment using the PPT.

Secondary Outcome Measures

Name	Time	Method
Cognitive functions: Stroop Test-Interference Form	eight weeks	The Stroop test is a cognitive assessment that evaluates executive functions and measures attention, the inhibition of inappropriate automatic responses, and perception under disruptive influence. The Stroop effect not only measures executive functions but also assesses processing speed, automatic, and parallel processing. The Stroop effect occurs when there is a conflict between the color name written and the color used to write it. When the colors are different, reading the word becomes slower compared to reading words that are written in the same color, and the difference between these two speeds is referred to as the Stroop effect. The Stroop effect not only measures executive functions but also assesses processing speed, automatic, and parallel processing. A longer completion time and a higher error count indicate weak cognitive flexibility. Patients will be evaluated pre- and post-treatment using the Stroop test.
Postural Assessment Scale for Stroke Patients	eight weeks	The Postural Assessment Scale for Stroke Patients (PASS) is designed to evaluate postural control and balance in detail. The scale assesses balance during tasks such as lying, sitting, standing, or changing positions. Each task is rated from 0 (lowest) to 3 (highest). The total score ranges from 0 to 36. Higher scores on the PASS indicate better postural stability and functional independence, with a maximum score of 36 representing full postural competence. Patients will be evaluated pre- and post-treatment using the PASS.
Trunk functions: Body Disorder Scale (BDS)	eight weeks	BDS is a tool used to assess motor dysfunctions resulting from stroke and to measure the quality of body movements. The scale consists of 17 parameters and is used to evaluate somatic, motor, and coordination deficits in stroke patients. The scale is divided into three subcategories: static sitting balance, dynamic sitting balance, and coordination. The total score ranges from 0 to 23 points, with higher scores indicating better performance. Patients will be evaluated pre- and post-treatment using the BDS.

Trial Locations

Locations (1)

Başkent University; 🇹🇷 Ankara, Türkiye, Turkey